SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-048663
Filing Date
2024-04-26
Accepted
2024-04-26 07:56:37
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a_2023.htm DEFA14A 12532
2 GRAPHIC img243671804_0.jpg GRAPHIC 494034
3 GRAPHIC img243671804_1.jpg GRAPHIC 312561
  Complete submission text file 0000950170-24-048663.txt   1124144
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

IRS No.: 854012572 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41855 | Film No.: 24878838
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)